Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Southwest Hospital, China
University of Maryland, Baltimore
H. Lee Moffitt Cancer Center and Research Institute
University of Texas Southwestern Medical Center
Shenzhen Geno-Immune Medical Institute
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
University of Southern California
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
M.D. Anderson Cancer Center